Table 2.
General anesthesia |
Local/Regional anesthesia |
Outcomes |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Authors | Anesthetic | No. of patients | Average total costs (USD) | Type | Anesthetic | No. of patients | Average total costs (USD) | Main findings about cost analysis (primary outcome)) | Other study findings (secondary outcomes) | Resources included for the calculation of costs |
Li et al.10 | NR | 3,903 | 15,670 | Loco-regional anesthesia | NR | 1,576 | 19,929 | Average total costs were significantly higher in patients undergoing regional anesthesia. | Several other contributors to higher costs are described. | Medical procedure costs |
Bokshan et al.11 | NR | 3,737 | 19,249 | Loco-regional anesthesia | NR | 10,976 | 17,469 | Average total costs were significantly lower in patients undergoing regional anesthesia. | General anesthesia, Hispanic ethnicity, Chronic medical condition, male gender, operative time and age are predictors of increased costs. | Medical procedure costs |
Gebhardt et al.12 | Sulfentanil and Propofol | 25 | 71.92 | SA | Chloroprocaine 1% | 25 | 41.02 | Anesthesia costs are inferior in case of regional anesthesia. | Spinal had faster recovery with patients reaching discharge earlier (117 vs. 142 min)*. Pain occurred earlier in the general anesthesia group. Patients felt significantly more uncomfortable after general anesthesia. | Anesthesia costs |
Hamilton et al.13 | Volatile anesthetics or intravenous with propofol | 241 | 60 | Interscalene brachial plexus single shot block, or catheter | 20–40 mL of 0.5% ropivacaine with 1:400,000 epinephrine | 1,382 | 82 | No statistically significant difference between groups. | Increased risk of an emergency department visit within 30 days for patients who received a regional anesthesia. | Costs incurred after surgery |
Chandran et al.14,a | NR | 6 | 2071 | LA | NR | 14 | 1251 | Average total costs of injection laryngoplasty under LA are significantly lower than under GA with cost savings of 40%. Major contributors are direct and indirect operating theater costs. | Length of stay (h): 8.8 GA vs 6.4 LA* | Medical procedure costs |
Camponovo et al.15 | Intravenous propofol and fentanyl | 28 | 104 | SA | Chloroprocaine 1% | 28 | 63 | SA for knee arthroscopy is associated with cost reductions per patient compared with GA. Cost reductions in the SA group are due to: the ability to systematically bypass the PACU, faster discharge time, the lower incidence of pain and postoperative nausea and vomiting. | Anesthesia time: 64 vs. 62 min. | Anesthesia supplies, drugs, staff |
Discharge time: 326 (GA) vs 203 min (SA)* | ||||||||||
Penketh et al.16 | NR | NR | 1,485 | LA in operatory room | NR | NR | LA in operatory room: 716 | Operative hysteroscopic resection under LA is less expensive than under GA, especially if performed in the office compared to the OR. Reduced staff costs are the primary reason for saving. | NR | Medical procedure costs |
LA in office | LA in office: 482 | |||||||||
Sivalingam et al.17 | NR | 73 | 30,060 | LA | Lidocaine 1%b | 46 | 7,770 | Average total cost is nearly 4 times greater for the GA group compared to LA. Ureteral stent placement can be safely and effectively performed under LA in the office. | No difference in complications between GA and LA. | Medical procedure costs |
Ahonkallio et al.18,c | NR | 20 | 2,333 | Peripheral block | 20 mL ropivacaine 2 mg mL−1,d | 16 | 1,333 | Endometrial thermal ablation under PB is cheaper than GA and results in significantly reduced health service costs. The difference is due to lower costs of the hospital ward and anesthesia, and partly to overhead costs. | NR | Medical procedure costs |
Covarelli et al.19,a | NR | 41 | 373 | LA | 10−25 mL 1% mepivacaine and 0.5% L-bupicavaine in equal parts | 112 | 258 | Average total costs for groin and axillary sentinel lymph node biopsy under GA are significantly higher than those under LA. | No differences in the number of complications. | Operating room management, personnel, drugs, instruments |
Stoffels et al.20 | NR | 89 | 500 | LA | 450 mL physiological solution, 50 mL Lidocain 1%, 0.5 mg Epinephrin | 211 | 47 | The costs were significantly less in a procedures room performed under local anesthesia compared to general anesthesia in an operating room. | No differences in the number of postoperative complications nor in oncological outcomes. | Anesthesia costs |
Mitchell et al.21,a | NR | 64 | 1,244 | LA | NR | 47 | 1,026 | Sacral nerve stimulation under LA is associated with reduced costs compared to GA. | LA is associated with shorter hospital staye and quicker recovery. | Medical procedure costs |
Similar symptom score and success rate for both anesthesia. | ||||||||||
Kushwaha et al.22 | Propofol 1.5−2 mg kg−1 and fentanyl 10 μg kg−1 with sevofluranef | 22 | 714 | LA | 20 mL 1% lidocaine with 1:10,000 epinephrine | 19 | 503 | Excluding the cost of post-operative follow-up, LA was 1.5 times cheaper than GA. This difference is due to the saving in GA and recovery room costs. | LA is associated with similar tolerance and clinical outcome compared to GA. | Suture materials, drugs, day surgery bed, staff costs, recovery room, post-operative medication. |
Mostafa et al.23 | Intravenous remifentanil 0.5 μg kg−1 min−1 or alfentanil 2 μg kg−1 min−1 and propofol 9 mg kg−1 h−1 | 40 | 492 for remifentanil | Sciatic-femoral nerve block | 25 mL ropivacaine | 20 | 393 | Costs of disposals, pre-operative and post-operative times are higher for the sciatic-femoral block group, however average total costs (including also drugs) are insignificant between GA and sciatic-femoral nerve block. | Length of stay in PACU: 28 min for remifentanil GA vs 25 min for alfentanil GA vs 28 for sciatic-femoral nerve block | Disposal, drugs, staff |
541 for alfentanil | ||||||||||
Horn et al.24,a | Propofol with sevoflurane or desflurane, fentanyl or sufentanyl | 121 | 4,780 | Peripheral nerve block | Mepivacaine 1.5% with 10% sodium bicarbonate | 92 | 3,656 | Perioperative costs in the peripheral nerve block group are significantly lower than in the GA group. | PACU time: 49 min (GA) vs 15 min (PNB)* | Medical procedure costs |
The use of peripheral nerve block in upper extremity surgery is feasible and associated to significant cost savings. | Postoperative complications: 11.7% (GA) vs 3.3% (PNB)* | |||||||||
Nishikawa et al.25 | Intravenous fentanyl 1 μg kg−1 and propofol 6 mg kg−1 h−1 | 40 | 74 | SA | Lidocaine 1% 1 m L | 40 | 49 | Average total costs are significantly lower in the SA group. Costs of drugs and supplies used in the operatory room are reduced for the SA, whereas the labor costs are higher in both operatory room and recovery unit. | Time to home-readiness: 30 min (GA) vs 38 min (SA)* | Drugs, equipment, staff |
No pain in the recovery unit for 75% patients in GA vs 80% patients SA groups. * | ||||||||||
SA may be a suitable cost-effective alternative to GA for elderly ambulatory prostate biopsy. | No adverse events at home. | |||||||||
Nordin et al.26,a | NR | 199 | 2,964 | SA/epidural anesthesia | SA/epidural anesthesia: NR | SA/epidural anesthesia: 164/35 = 199 | SA/epidural anesthesia: 3,010 | Average total costs of LA are significantly lower than the other two groups. Intra-operative (anesthetic equipment, duration of surgery and anesthesia) and post-operative (time in recovery room, unplanned overnight admission) costs are reduced for LA compared to SA/epidural anesthesia and GA. No difference between SA/epidural anesthesia and GA. | NR | Medical procedure costs |
LA | LA: 50:50 mixture of 1% mepivacaine and 0.5% bupicavaine | LA: 205 | LA: 2,508 | |||||||
Spanknebel et al.27 | NR | 85 | 3,153 | LA | Lidocaine and bupicavaine | 217 | 2,760 | Average total costs are significantly higher for GA than LA. Extensive procedures and increased operating room times impact significantly on costs. | Thyroidectomy under LA results in similar outcome and morbidity rate to GA with reduced costs. | Medical procedure costs |
Casati et al.28 | Intravenous remifentanil 0.1−0.3 μg kg−1 min−1 and propofol 2−4 μg mL−1 | 40 | 317 | sciatic-femoral nerve block SA | sciatic-femoral nerve block: 25 mL 2% mepivacaine | sciatic-femoral nerve block: 40 | sciatic-femoral nerve block: 220 | The use of sciatic-femoral nerve block results in the lowest total costs. Costs of drugs and disposable material required for anesthesia are lower in the SA group than the others. | Regional anesthesia techniques reduce the rate of admission and the duration of stay in the PACU as compared with GA. | Drugs, devices, staff |
SA: 8 mg 0.5% bupicavaine | SA: 40 | SA: 308 | The time readiness for home discharge are shorter in the GA group than regional anesthesia. | |||||||
Forssblad et al.29 | Propofol and alfentanil | 88 | 236 | LA | LA: 30 mL 0.5% prilocaine with 4 μg mL−1 adrenaline | LA: 181 | LA: 76 | The knee arthroscopy in LA is associated with lower cost than knee arthroscopy in SA and GA, because of the shorter recovery time of LA that reduces the need for recovery beds and postoperative care. | Recovery time: 139.1 min (GA) vs 33.6 min (LA) vs 230.1 min (SA). | Drugs, devices, staff |
SA | SA: 60−90 mg 5% lidocaine with 5−10 mg ephedrine | SA: 74 | SA: 219 | Time in hospital: 280.4 min (GA) vs 130.4 min (LA) vs 350.3 min (SA) | ||||||
Casati et al.30 | Intravenous remifentanil 0.1−0.3 μg kg−1 min−1 and propofol 2−4 μg mL−1 | 20 | 291 | Sciatic-femoral nerve block | 25 mL 2% mepivacaine | 20 | 288 | Average total costs between GA group and sciatic-femoral block group in patients undergoing knee arthroscopy are not statistically significant. Costs related to the time spent in the PACU are statistically significant lower for the sciatic-femoral block group (USD 2.0) compared with the GA group (USD 55.7). | Time in the hospital: 170 min (GA) vs 277 min (Sciatic-femoral block)* | Disposable materials, drugs, staff |
Length of stay in PACU: 23 min (GA) vs 5 min* | ||||||||||
VAS pain: 7 (GA) vs 0* | ||||||||||
Danelli et al.31 | Intravenous remifentanil 0.25 μg kg−1 min−1 and propofol 4 μg mL−1 | 20 | 260 | SA | 10 mg 0.5% bupivacaine | 20 | 282 | No differences in average total costs between the two groups. | Hospital discharge time: 156 min (GA) vs 296 min (SA)* | Disposable materials, drugs, staff |
Pain control is similar. | ||||||||||
Lennox et al.32 | Fentanyl 2 μg kg−1 and propofol 2 mg kg−1, 65% nitrous oxide | 10 | 127 | SA | 3 mL 10 mg lidocaine and 10 μg sufentanil | 10 | 94 | Average total cost of anesthesia and recovery is significantly less for patients in the SA group than the GA group. Recovery costs are similar, whereas mean costs of anesthesia is significantly less in the SA group. Cost savings are due to lower cost of anesthetic supplies, sterilization, drugs. | Anesthesia time: 6.6 min (GA) vs 6.6 min (SA) | Supplies, drugs, staff |
PACU time: 112 min (GA) vs 101 min (SA) | ||||||||||
Postoperative pain: 50% (GA) vs 0% (SA)* | ||||||||||
Nausea/vomiting: 0% (GA) vs 30% (SA) | ||||||||||
Chan et al.33 | Propofol, fentanyl, with isoflurane (up to 1.5%), 60% nitrous oxide | 39 | 718 | Intravenous regional anesthesia | Intravenous regional anesthesia: 35−45 mL 0.5% lidocaine | Intravenous regional anesthesia: 45 | Intravenous regional anesthesia: 513 | The intra- and post-operative costs are the least in the intravenous regional anesthesia group than GA and axillary block, reflecting cost savings of approximately 30% in both cases. intravenous regional anesthesia is associated with short induction time, lower anesthetic drug and equipment costs in the operatory room, and with less demand on nursing time and lower drug and supply costs in the PACU. | Total hospital stay time: 240 min (GA) vs 180 min (intravenous regional anesthesia)*vs 244 min (axillary block) | Disposable materials, drugs, staff |
Axillary block | Axillary block: 40−50 mL 3% chloroprocaine and 2% or 1.5% lidocaine with 1:200,000 epinephrine | Axillary block: 42 | Axillary block: 755 | Anesthesia time: 83 min (GA) vs 72 min (intravenous regional anesthesia)*vs 106 min (axillary block) | ||||||
PACU recovery time: 70 min (GA) vs 45 min (intravenous regional anesthesia)*vs 63 min (axillary block) | ||||||||||
Martikainen et al.34 | Intravenous propofol 2 mg kg−1 and alfentanil 1 mg with sevoflurane (up to 8%) | 30 | 333 | SA | 3 mL 2% lidocaine | 30 | 293 | Average total costs are significantly reduced for SA. However, GA is more cost-effective than SA in ambulatory knee surgery, if a short recovery unit time is required. | Recovery unit time: 218 min (GA) vs 224 min (SA) | Disposable materials, drugs, staff |
Time to home-readiness: 96.4 min (GA) vs 140.8 min (SA)* | ||||||||||
Post-operative pain low (VAS < 4 in 100% patients in SA vs in 86.7% in GA groups). | ||||||||||
Chilvers et al.35 | Propofol, fentanyl or sufentanil, and mivacurium or succinylcholine, with isoflurane nitrous oxide | 28 | 99 | SA | 2−2.5 mL 1% lidocaine and 10−25 μg fentanyl | 24 | 107 | Average total costs for anesthesia and recovery are similar between the two groups. Use of SA in alternative to GA does not reduce costs or improve efficacy of anesthesia and recovery for outpatient laparoscopy. | Anesthesia time: 10 min (GA) vs 18 min (SA)* | Disposable materials, drugs, staff |
PACU recovery time: 94 min (GA) vs 123 min (SA)* | ||||||||||
Time to discharge: 124 min (GA) vs 150 min (SA) | ||||||||||
Li et al.36 | Intravenous propofol 2.5 mg kg−1, fentanyl 1−2 μg kg−1 with 0.5−2% sevoflurane, 65% nitrous oxide | 31 | 289 | SA | SA: 30 mg lidocaine and 20 μg fentanylg | SA: 31 | SA: 208 | Average total costs are significantly decreased for LA than SA and GA because both intraoperative and recovery costs are the lowest. Patients in the LA group are able to by-pass phase 1 recovery unit requiring less nursing labor (thus less costs). GA is associated to the highest costs. | Anesthesia time: 40 min (LA) vs 72 min (SA)* vs 75 min (GA)* | Drugs, supplies, staff |
LA with sedation | LA: 31 | LA: 138 | Phase 1 stay: 0 (LA) vs 52 min (SA)*vs 44 min (GA)* | |||||||
LA: topical 2% lidocaine gel and sedation-analgesia with propofol 75 μg kg−1 min−1 and 0.5 μg kg−1 fentanyl. 15 mL 2% lidocaine, 15 mL 0.5% bupicavaine, 0.5% epinephrine (1:200,000) | Time to home-readiness: 76 min (LA) vs 193 min (SA)*vs 171 min (GA)* | |||||||||
Hospital stay: 116 min (LA) vs 266 min (SA)*vs 247 min (GA)* | ||||||||||
No differences in post-operative side effects or unanticipated hospitalizations. | ||||||||||
Song et al.37 | Propofol 2.5 mg kg−1 min−1 1% sevoflurane, 65% nitrous oxide | 28 | 369 | SA | SA: 1.2−1.5 mL 0.75% bupicavaine and 25 μg fentanyl | SA: 25 | SA: 330 | Average total costs are the lowest for the ilioinguinal-hypogastric nerve block group (reduced supplies during the intraoperative period, reduced labor during post-operative period). No difference between GA and SA. | Anesthesia time: 109 min (ilioinguinal block) vs 119 (GA) vs 116 (SA) | Drugs, staff, resources |
Ilioinguinal-hypogastric nerve block | Ilioinguinal-hypogastric nerve block: 30 mL of 0.25% bupivacaine, 1% lidocaine and propofol 25−150 μg kg−1 min−1 | Ilioinguinal-hypogastric nerve block: 28 | Ilioinguinal-hypogastric nerve block: 288 | Ilioinguinal-hypogastric nerve block is the most cost-effective techniques for outpatients undergoing unilateral herniorrhaphy with respect to recovery, patient comfort, and associated incremental costs. | Phase 1 PACU: 5 min (ilioinguinal block) vs 40 (GA)*vs 35 (SA)* | |||||
Phase 2 unit: 153 min (ilioinguinal block) vs 168 (GA) vs 276 (SA)* | ||||||||||
Time to home-readiness: 133 min (ilioinguinal block) vs 171 (GA)*vs 280 (SA)* | ||||||||||
Time to actual discharge: 158 min (ilioinguinal block) vs 208 (GA)*vs 309 (SA)* | ||||||||||
Maximum pain VAS: 15 (ilioinguinal block) vs 39 (GA)*vs (34) SA* | ||||||||||
Maximum nausea VAS: 1 (ilioinguinal block) vs 27 (GA)*vs 4 (SA)* |
NR, not reported; PACU, post-operative anesthesia care unit. Currency is expressed with United States dollars (USD). Type of anesthesia: GA, general anesthesia; LA, local anesthesia; SA, spinal anesthesia.
Day-case setting.
Four patients received also i.v. midazolam.
Day-case setting (8 h) for general anesthesia and outpatient setting (4 h) for paracervical block.
When necessary also Alfentanil 0.5 mg.
Overnight stay for 38% of patients of the GA group due to adverse effects of the anesthesia.
This group received also a perianal block as for the LA group.
Patients received also 1−2 mg midazolam i.v. for sedation.
Statistically significant.